ShangPharma Corp (SHP)

Currency in USD
7.90
0.00(0.00%)
Closed·
Showing ShangPharma Corp historical data. For real-time data please try another search
Day's Range
7.888.13
52 wk Range
0.008.13
Key Statistics
Prev. Close
7.9
Open
8.13
Day's Range
7.88-8.13
52 wk Range
0-0
Volume
-
Average Volume (3m)
125.13K
1-Year Change
-11.73%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

ShangPharma Corp News & Analysis

Show more

ShangPharma Corp Company Profile

ShangPharma Corporation, through its subsidiaries, operates as a pharmaceutical and biotechnology research and development outsourcing company. It offers various integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company’s services include discovery chemistry, discovery biology and preclinical development, pharmaceutical development, and biologics services. Its discovery chemistry services consist of medicinal chemistry, synthetic chemistry, library generation, and analytical chemistry; and discovery biology and preclinical development services comprise assay development and high throughput screening, pharmacology, reagent generation, and target validation and biomarker research, as well as DMPK, early formulation, in vitro ADME profiling, metabolite identification, bioanalytical services, and non-GLP toxicology. The company pharmaceutical development services include preformulation and formulation, process research and development, analytical development and validation, and research manufacturing; and biologics services consist of therapeutic antibody generation, antibody optimizing and engineering, and analytical services for large molecules. ShangPharma Corporation provides its services primarily in North America, Europe, China, and Japan. The company was founded in 2002 and is headquartered in Shanghai, China. As of March 28, 2013, ShangPharma Corporation was taken private.

Earnings

Latest Release
Mar 11, 2019
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

SHP Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.